Discovery of a new type of Killer T-Cell, the Super Killer T-Cell, could pave the way for more effective cancer treatments for late stage cancers.
Get more Great News in the GREAT NEWS LETTER!
Sign up today!
“We essentially cured some animals with just a few injections,” said Jennifer Cochran, PhD, the Shriram Chair of the Department of Bioengineering. “It was pretty astonishing. When we looked within the tumors, we saw they went from a highly immunosuppressive microenvironment to one full of activated B and T cells — similar to what happens when the immune-stimulating molecule is injected directly into the tumor. So, we’re achieving intra-tumoral injection results but with an IV delivery.”